BTIG raised the firm’s price target on AppLovin (APP) to $437 from $432 and keeps a Buy rating on the shares ahead of its Q4 results. The firm ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.65% of ...
BTIG lowered the firm’s price target on Prologis (PLD) to $134 from $154 and keeps a Buy rating on the shares ahead of its Q4 results. The ...
BioNano Genomics Inc (BNGO) stock saw a decline, ending the day at $0.19 which represents a decrease of $-0.02 or -9.52% from the prior close of $0.21. The stock opened at $0.21 and touched a low of ...
Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation.
BTIG analysts upheld their Buy rating and a $140.00 price target for Kirby Corporation (NYSE:KEX) stock, a leading tank barge operator in the United States. The firm's analysts highlighted that ...
Prologis (NYSE:PLD – Get Free Report) had its price objective cut by analysts at BTIG Research from $154.00 to $134.00 in a report released on Friday. The brokerage currently has a “buy” rating on the ...
BTIG announced today that it will commit to donating $1 million dollars to wildfire relief and restoration efforts in Los Angeles, California. The funds will be donated to reputable organizations ...
The economic fundamentals of Wednesday's inflation report will doubtless impact stocks. But before that let's have a chartist view from BTIG's technical guru Jonathan Krinsky. He notes that the S&P 50 ...
BTIG raised the firm’s price target on Insulet (PODD) to $300 from $270 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models in select Medical ...
BTIG analyst Jake Fuller says that while Uber‘s (UBER) commentary on its U.S. rideshare business “felt constructive” at intra-quarter appearances, the firm’s receipt data was “more ...
The non-QM segment industry-wide had a 25% increase in issuance dollar volume during 2024 as market conditions for private-label securitization were better.